Last reviewed · How we verify

NCT04876547: APPENDECTOMY

Are Cesarean Section and Appendectomy in Pregnancy and Puerperium Interrelated?

Completed Last updated 6 May 2021
What this trial tests

trial testing appendectomy in Appendicitis Acute in 32 participants. Completed in 1 October 2020.

Timeline
1 January 2015
Primary endpoint
1 October 2020
1 October 2020

Quick facts

Lead sponsorAmasya University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date1 January 2015
Primary completion1 October 2020
Estimated completion1 October 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Amasya University

Who can join

Adults 18 to 45, female only, with Appendicitis Acute or Cesarean Wound Disruption With Postnatal Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is not known whether appendectomy for acute appendicitis (AA) increases the Cesarean section (CS) rate and whether CS increases the likelihood of AA and appendectomy in the early puerperium. In this study, delivery type and delivery outcomes and appendectomy during pregnancy and puerperium were analyzed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Are Cesarean Section and Appendectomy in Pregnancy and Puerperium Interrelated? A Cohort Study.
    Şahin B, Tinelli A, Augustin G. · · 2022 · cited 4× · PMID 35252336 · DOI 10.3389/fsurg.2022.819418

Verify or expand the search:

Other trials of appendectomy

Trials testing the same drug.

Other recruiting trials for Appendicitis Acute

Currently open trials in the same condition.

Other Amasya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04876547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing